Abstract
Two Japanese chemical companies are increasing their presence in the active pharmaceutical ingredient (API) business. Sumitomo Chemical says it will build a third plant in Japan—this one in Oita City—for small-molecule APIs and intermediates. The firm says the project will enhance its leading position in Japan. Meanwhile, AGC says it will spend $100 million to expand its small-molecule API plant in Malgrat de Mar, Spain. AGC acquired the facility in 2019.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
